With more than 1.9 million new cancer cases expected to be diagnosed in the U.S. in 2023, according to the American Cancer Society (ACS), screenings are critical to detect the disease in its early ...

Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing ...

Please provide your email address to receive an email when new articles are posted on . The benefits of type 1 diabetes screening have long been up for debate, but FDA approval of the first therapy to ...

(WXYZ) — November is Diabetes Awareness Month; it’s a disease that affects millions of people across the United States – both with type one and type two. Type ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.

Poster highlights how healthcare expertise and lived screening experience together can help individuals move from ...

The recent approval of teplizumab-mzwv (Tzield, Provention Bio) for the delay of type 1 diabetes by the US Food and Drug Administration is expected to advance efforts to increase screening to ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...